International Agency for Research on Cancer. Global cancer
observatory: cancer today [EB/OL]. [2022 -06
-22].https://gco.iarc.fr/today/online-analysis-table.
Zheng R,Zhang S,Zeng H,et al. Cancer incidence and mortality in
China,2016[J]. J Natl Cancer Cent,2022,2(1):1-9.
Bras A L,Gomes D,Filipe P A,et al.Trends,seasonality and forecast of
pulmonary Tuberculosis in Portugal.[J].International Journal of
Tuberculosis &Lung Disease,2014,18 (18):1202-1210.
LUGO⁃VILLARINO G,TROEGELER A,BALBOA L,et al. The C⁃type lectin
receptor DC⁃SIGN has an anti⁃inflammatory role in human M(IL ⁃
4)macrophages in response to Mycobacterium tuberculosis[J]. Front
Immunol,2018,9:1123.
AN X,LI W,PAN L,et al. Lewis lung cancer cells promote
SIGNR1(CD209b)⁃mediated macrophages polarization induced by IL⁃4 to
facilitate immune evasion[J]. JCell
Biochem,2016,117(5):1158-1166.
YU Y H,LIAO C C,HSU W H,et al. Increased lung cancer risk among
patients with pulmonary tuberculosis:a population cohortstudy[J].
J Thorac Oncol,2011,6(1):32-37.
NALBANDIAN A,YAN B S,PICHUGIN A,et al. Lung carcinogenesis induced
by chronic tuberculosis infection:the experimental model and genetic
control[J]. Oncogene,2009,28(17):1928-1938
Shaodi Wen, Bo Shen. Immunotherapy mechanism and clinical research
status of non-small cell lung cancer [J] Journal of Nanjing
Medical University (Natural Science Edition), 2020, 40 (11):
1739-1746ZAEMES J,KIM C. Immune checkpoint inhibitor use and
tuberculosis:a systematic review of the literature[J]. Eur J
Cancer,2020,132:168-175
CHRISTOPOULOS A,SAIF M W,SARRIS E G,et al. Epidemiology of active
tuberculosis in lung cancer patients:a systematic review[J]. Clin
Respir J,2014,8(4):375-381.
Takwoingi Y, Whitworth H, Rees-Roberts M, et al. Interferon gamma
release assays for Diagnostic Evaluation of
Activetuberculosis(IDEA):test accuracy study and economic evaluation.
Health Technol Assess,2019,23(23):1-152.doi:10.3310/hta23230.
Lang S, Sun J, Wang X, et al. Asymptomatic pulmonary tuberculosis
mimicking lung cancer on imaging: A retrospective study. Exp Ther
Med,2017,14(3):2180-2188.doi:10.3892/etm.2017.4737.
Henschke CI, Yankelevitz DF, Miettinen OS. Computed tomographic
screening for lung cancer:the relationship of disease stage to tumor
size.Arch Intern Med,2006,166(3):321-325.
Wen Limin, Hou Dailun. Current status and progress of imaging
evaluation methods for detecting pulmonary tuberculosis combined with
lung cancer. Chin J Antituberc, June 2023, Vol. 45, No.6.
Niyonkuru A, Chen X, Bakari KH, et al. Evaluation of the diagnostic
efficacy of 18F-Fluorine-2-Deoxy-D-Glucose PET/CT for lung cancer and
pulmonary tuberculosis in a Tuberculosisendemic Country. Cancer
Med,2020,9(3):931-942.
Guangchuan Dai, Chunyang Yin, Shanshan Chen, et al. One case had
coexisting tuberculosis and lung cancer in the same lesion. Collection
of papers of the 34th National Academic conference of the Chinese
anti-tuberculosis Association.
Sipei Zhang,Lijuan Chen,Jianwen Qin,et al. Discussion on drug use in a
patient with lung adenocarcinoma complicated with active pulmonary
tuberculosis: a case report. Journal of Tianjin Medical University,
Volume 29, Issue 4, July 2023.
Zelin Xiao, Jianqi Gao, Jiajie Liu,et al. Prognostic significance of
surgical treatment in patients with NSCLC complicated with active
pulmonary tuberculosis. Chinese Journal of Lung Diseases (electronic
edition) June 2022, Volume 15, Issue 3.
Guidelines for the Diagnosis and treatment of liver injury with
anti-tuberculosis drugs, Chinese Association of Tuberculosis Society
(2019 edition).
Xiaoxin He, Bo Li and Lin Zhou. ”Observation on the efficacy of
4-month anti-tuberculosis treatment regimen containing Rifapentine”
Interpretation of Chinese Journal of National Defense Consumption,
December 2021, volume 43, Issue 12.
Rui Jiao Ma, Zhili Jia, Xuefang Wang,et al. Comparative study of liver
toxicity of anti-tuberculosis drugs based on zebrafish model Chinese
Journal of Antibiotics September 2020 Vol.45, No.9.
Expert consensus on the treatment of chronic kidney disease
complicated with tuberculosis by Chinese Society of Tuberculosis (2022
edition).
Zhenzhu Zhu Functional Design and Mechanism of Action of
platinum-based
drugs against tumor, Doctoral Dissertation, Inorganic Chemistry, Nanjing
University, May 1, 2016.